Clinical Trial Update: Assessing Antiviral Treatments in Early Symptomatic RSV [Phase 2]

View source ↗

Summary

Phase 2 clinical trial led by the University of Oxford is evaluating antiviral treatments for early symptomatic respiratory syncytial virus infection and is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Snippet

Sponsor: University of Oxford | Conditions: Respiratory Syncytial Virus, Respiratory Syncytial Virus, Human | Phase 2 | Status: RECRUITING